Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2020 | Story Lacea Loader

Update: 26 January 2020
Bloemfontein Campus registration process to continue on Monday 27 January 2020


The registration process for students on the Bloemfontein Campus of the University of the Free State (UFS) will continue on Monday 27 January 2020 as per the registration programme.

First-year students who have not registered must refer to their email, the university’s self-service portal, and the Call Centre (051 401 9666) for information. Senior students can visit registration venues on campus if they require academic advice.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393



Update: 24 January 2020
Bloemfontein Campus registration process not to continue the afternoon of Friday 24 January 2020  


The first-year registration process on the Bloemfontein Campus will not continue after 13:00 today (Friday 24 January 2020), but will resume on Monday 27 January 2020.

This decision taken by the executive management of the university comes after a number of students disrupted the registration process this morning and prevented first-year students to enter registration venues.

Constant engagements with the Institutional Student Representative Council (ISRC) and the Student Representative Council (SRC) of the Bloemfontein Campus have taken place since the beginning of the year regarding matters of concern to students, and the executive management will continue to do so. The university management is disappointed with this morning’s disruptive behaviour led by the Bloemfontein Campus SRC, despite these regular engagements.

The situation on the campus is being closely monitored by the university’s Protection Services and the South African Police Service.

 

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept